Low Versus Standard Dose of Rituximab in Adult Patients with Relapsed or Refractory Primary Membranous Nephropathy: Does It Make Any Difference?

oleh: Şafak Mirioğlu, Arif Akyıldız, Ali Rıza Uçar, Ömer Uludağ, Yasemin Öztürk, Ahmet Burak Dirim, Erol Demir, Özgür Akın Oto, Işın Kılıçaslan, Yaşar Çalışkan, Halil Yazıcı, Aydın Türkmen, Mehmet Şükrü Sever

Format: Article
Diterbitkan: AVES 2023-07-01

Deskripsi

No description available for this item.